article_metadata: Ayako Nagayama Kenji Ashida Miki Watanabe Kanoko Moritaka Aya Sonezaki Yoichiro Kitajima Hirokazu Takahashi Satoko Yoshinobu Shimpei Iwata Junichi Yasuda Nao Hasuzawa Shuichi Ozono Seiichi Motomura Masatoshi Nomura
article_metadata: 10.3389/fendo.2021.690996
article_metadata: Front Endocrinol (Lausanne)
article_metadata: 2021 May 31;12:690996.
article_metadata: sglt2 inhibitor diabetes mellitus hypertriglyceridemia lipodystrophy metreleptin
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34135866/
article_metadata: Benzhydryl Compounds / therapeutic use Bone Marrow Transplantation / adverse effects Glucosides / therapeutic use Leptin / analogs & derivatives Lipodystrophy / drug therapy Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
article_metadata: Benzhydryl Compounds / therapeutic use Bone Marrow Transplantation / adverse effects Glucosides / therapeutic use Leptin / analogs & derivatives Lipodystrophy / drug therapy Sodium-Glucose Transporter 2 Inhibitors / therapeutic use Case Reports Drug Therapy, Combination Female Humans Hypoglycemic Agents / therapeutic use Leptin / therapeutic use Lipodystrophy / etiology Pioglitazone / therapeutic use Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy Treatment Outcome Young Adult Benzhydryl Compounds Glucosides Hypoglycemic Agents Leptin Sodium-Glucose Transporter 2 Inhibitors empagliflozin metreleptin Pioglitazone Lipodystrophy, Partial, Acquired
article_metadata: PMC8201990
article_metadata: 34135866
article_metadata: Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
article_metadata: 2021